PNC Financial Services Group’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8K Sell
429
-291
-40% -$4.93K ﹤0.01% 4155
2026
Q1
$11.4K Sell
720
-674
-48% -$14.6K ﹤0.01% 3899
2025
Q4
$36.6K Sell
1,394
-102
-7% -$2.65K ﹤0.01% 3378
2025
Q3
$33.8K Sell
1,496
-1,418
-49% -$29.2K ﹤0.01% 3398
2025
Q2
$57.9K Sell
2,914
-648
-18% -$12.6K ﹤0.01% 3028
2025
Q1
$60.2K Buy
3,562
+1,963
+123% +$33.4K ﹤0.01% 2987
2024
Q4
$29.5K Sell
1,599
-2,046
-56% -$39.9K ﹤0.01% 3357
2024
Q3
$79.2K Sell
3,645
-195
-5% -$4.36K ﹤0.01% 2808
2024
Q2
$75.3K Buy
3,840
+3,395
+763% +$70.9K ﹤0.01% 2802
2024
Q1
$9.66K Buy
445
+31
+7% +$770 ﹤0.01% 3761
2023
Q4
$12K Sell
414
-2,074
-83% -$55.5K ﹤0.01% 3659
2023
Q3
$66.5K Sell
2,488
-901
-27% -$30.8K ﹤0.01% 2803
2023
Q2
$125K Buy
3,389
+826
+32% +$28.8K ﹤0.01% 2501
2023
Q1
$80K Buy
2,563
+1,059
+70% +$34.1K ﹤0.01% 2705
2022
Q4
$44.8K Buy
1,504
+202
+16% +$7.23K ﹤0.01% 3047
2022
Q3
$51K Sell
1,302
-1,038
-44% -$52K ﹤0.01% 2957
2022
Q2
$128K Sell
2,340
-688
-23% -$37.8K ﹤0.01% 2405
2022
Q1
$189K Sell
3,028
-504
-14% -$33.2K ﹤0.01% 2298
2021
Q4
$356K Buy
3,532
+1,917
+119% +$168K ﹤0.01% 1908
2021
Q3
$145K Sell
1,615
-73
-4% -$6.63K ﹤0.01% 2396
2021
Q2
$156K Sell
1,688
-1,134
-40% -$90.5K ﹤0.01% 2369
2021
Q1
$273K Buy
2,822
+2,015
+250% +$208K ﹤0.01% 1988
2020
Q4
$43K Buy
807
+801
+13,350% +$33.5K ﹤0.01% 2989
2020
Q3
$0 Buy
+6
New +$188 ﹤0.01% 3957

Other funds holding FLGT

PNC Financial Services Group's FLGT Position: Q2 2026 in Review

PNC Financial Services Group reduced its Fulgent Genetics (FLGT) stake by 40% in Q2 2026, selling an estimated $4.93K and leaving 429 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4155.

PNC Financial Services Group first reported a position in FLGT in Q3 2020 and has held it in 24 quarters since. The position peaked at $356K in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • PNC Financial Services Group held 429 shares of Fulgent Genetics worth $8.8K as of Q2 2026.
  • PNC Financial Services Group sold 291 Fulgent Genetics shares in Q2 2026, an estimated $4.93K.
  • Fulgent Genetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4155 holding.
  • PNC Financial Services Group first reported a position in Fulgent Genetics in Q3 2020 and has held it in 24 quarters since.
  • PNC Financial Services Group's Fulgent Genetics position peaked at $356K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.